These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

130 related items for PubMed ID: 2444244

  • 1. 5-Azacytidine and 5-aza-2'-deoxycytidine behave as different antineoplastic agents in B16 melanoma.
    Cortvrindt R, Bernheim J, Buyssens N, Roobol K.
    Br J Cancer; 1987 Sep; 56(3):261-5. PubMed ID: 2444244
    [Abstract] [Full Text] [Related]

  • 2. Differential effects of 5-azacytidine and 5-azadeoxycytidine on cytotoxicity, DNA-strand breaking and repair of X-ray-induced DNA damage in HeLa cells.
    Snyder RD, Lachmann PJ.
    Mutat Res; 1989 Jul; 226(3):185-90. PubMed ID: 2473395
    [Abstract] [Full Text] [Related]

  • 3. Toxicity of 5-aza-2'-deoxycytidine to mammalian cells is mediated primarily by covalent trapping of DNA methyltransferase rather than DNA demethylation.
    Jüttermann R, Li E, Jaenisch R.
    Proc Natl Acad Sci U S A; 1994 Dec 06; 91(25):11797-801. PubMed ID: 7527544
    [Abstract] [Full Text] [Related]

  • 4. Resistance of HL-60 promyelocytic leukemia cells to induction of differentiation and its reversal by combination treatment.
    Schwartsmann G, Pinedo HM, Leyva A.
    Eur J Cancer Clin Oncol; 1987 Jun 06; 23(6):739-43. PubMed ID: 2443360
    [Abstract] [Full Text] [Related]

  • 5. Heritable high frequency modulation of antigen expression in neoplastic cells exposed to 5-aza-2'-deoxycytidine or hydroxyurea: analysis and implications.
    Alvarez E, Elliott BE, Houghton AN, Kerbel RS.
    Cancer Res; 1988 May 01; 48(9):2440-5. PubMed ID: 2451561
    [Abstract] [Full Text] [Related]

  • 6. In vitro cytotoxic and biochemical effects of 5-aza-2'-deoxycytidine.
    Momparler RL, Goodman J.
    Cancer Res; 1977 Jun 01; 37(6):1636-9. PubMed ID: 66984
    [Abstract] [Full Text] [Related]

  • 7. Human concentrative nucleoside transporter 1-mediated uptake of 5-azacytidine enhances DNA demethylation.
    Rius M, Stresemann C, Keller D, Brom M, Schirrmacher E, Keppler D, Lyko F.
    Mol Cancer Ther; 2009 Jan 01; 8(1):225-31. PubMed ID: 19139132
    [Abstract] [Full Text] [Related]

  • 8. Comparative studies of the cytostatic action and metabolism of 5-azacytidine and 5,6-dihydro-5-azacytidine.
    Voytek P, Beisler JA, Abbasi MM, Wolpert-DeFilippes MK.
    Cancer Res; 1977 Jul 01; 37(7 Pt 1):1956-61. PubMed ID: 67884
    [Abstract] [Full Text] [Related]

  • 9. Inhibition of cytidine deaminase by zebularine enhances the antineoplastic action of 5-aza-2'-deoxycytidine.
    Lemaire M, Momparler LF, Raynal NJ, Bernstein ML, Momparler RL.
    Cancer Chemother Pharmacol; 2009 Feb 01; 63(3):411-6. PubMed ID: 18398609
    [Abstract] [Full Text] [Related]

  • 10. 3-Deazauridine (NSC 126849): an interesting modulator of biochemical response.
    Moriconi WJ, Slavik M, Taylor S.
    Invest New Drugs; 1986 Feb 01; 4(1):67-84. PubMed ID: 2422137
    [Abstract] [Full Text] [Related]

  • 11. Alpha anomer of 5-aza-2'-deoxycytidine down-regulates hTERT mRNA expression in human leukemia HL-60 cells.
    Hájek M, Votruba I, Holý A, Krecmerová M, Tloust'ová E.
    Biochem Pharmacol; 2008 Feb 15; 75(4):965-72. PubMed ID: 18045574
    [Abstract] [Full Text] [Related]

  • 12. Effect of 5-azacytidine on DNA methylation and the malignant properties of B16 melanoma cells.
    Trainer DL, Kline T, Mallon F, Greig R, Poste G.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6124-30. PubMed ID: 2415238
    [Abstract] [Full Text] [Related]

  • 13. Synergistic and additive combinations of several antitumor drugs and other agents with the potent alkylating agent adozelesin.
    Smith KS, Folz BA, Adams EG, Bhuyan BK.
    Cancer Chemother Pharmacol; 1995 Dec 15; 35(6):471-82. PubMed ID: 7533669
    [Abstract] [Full Text] [Related]

  • 14. Effect of uridine on response of 5-azacytidine-resistant human leukemic cells to inhibitors of de novo pyrimidine synthesis.
    Grant S, Bhalla K, Gleyzer M.
    Cancer Res; 1984 Dec 15; 44(12 Pt 1):5505-10. PubMed ID: 6208998
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the in vitro cytotoxicity (L1210) of 5-aza-2'-deoxycytidine with its therapeutic and toxic effects in mice.
    Covey JM, Zaharko DS.
    Eur J Cancer Clin Oncol; 1985 Jan 15; 21(1):109-17. PubMed ID: 2578963
    [Abstract] [Full Text] [Related]

  • 16. High degree of resistance to 5-aza-2'-deoxycytidine in L1210 cells in vitro associated with almost complete loss of deoxycytidine kinase activity.
    Veselý J.
    Neoplasma; 1987 Jan 15; 34(6):713-20. PubMed ID: 2448662
    [Abstract] [Full Text] [Related]

  • 17. 5-Aza-2'-deoxycytidine (Decitabine) and 5-azacytidine in the treatment of acute myeloid leukemias and myelodysplastic syndromes: past, present and future trends.
    Pinto A, Zagonel V.
    Leukemia; 1993 May 15; 7 Suppl 1():51-60. PubMed ID: 7683358
    [No Abstract] [Full Text] [Related]

  • 18. Pharmacological approach for optimization of the dose schedule of 5-Aza-2'-deoxycytidine (Decitabine) for the therapy of leukemia.
    Momparler RL, Côté S, Eliopoulos N.
    Leukemia; 1997 Mar 15; 11 Suppl 1():S1-6. PubMed ID: 9130684
    [Abstract] [Full Text] [Related]

  • 19. In vitro biochemical tests to evaluate the response to therapy of acute leukemia with cytosine arabinoside or 5-AZA-2'-deoxycytidine.
    Onetto N, Momparler RL, Momparler LF, Gyger M.
    Semin Oncol; 1987 Jun 15; 14(2 Suppl 1):231-7. PubMed ID: 2438776
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.